Invention Publication
- Patent Title: Ophthalmic Composition
-
Application No.: US17921065Application Date: 2021-03-31
-
Publication No.: US20230172969A1Publication Date: 2023-06-08
- Inventor: Tatsuya Ando , Yoko Mitsuguchi , Sachiko Matsumoto , Atsuko Nakata
- Applicant: Rohto Pharmaceutical Co., Ltd.
- Applicant Address: JP Osaka-shi, Osaka
- Assignee: Rohto Pharmaceutical Co., Ltd.
- Current Assignee: Rohto Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Osaka-shi, Osaka
- Priority: JP 20079971 2020.04.30
- International Application: PCT/JP2021/014059 2021.03.31
- Date entered country: 2022-10-24
- Main IPC: A61K31/737
- IPC: A61K31/737 ; A61K9/00 ; A61K31/23 ; A61K31/355 ; A61K31/205 ; A61K31/198 ; A61K31/27 ; A61K47/38 ; A61K31/4415 ; A61K31/16 ; A61P27/04 ; A61K31/4166 ; A61K31/704
Abstract:
The present invention relates to an ophthalmic composition for suppressing eye dryness, comprising at least one selected from the group consisting of chondroitin sulfate having a weight average molecular weight of 30,000 to 50,000 and a salt thereof.
Information query
IPC分类:
